Lifevantage (LFVN) Stock Price, News & Analysis

Company Overview

LifeVantage Corporation is a health and wellness company that develops, markets and sells dietary supplements, skincare products and other wellness offerings. Its products are designed to support areas such as cellular health, antioxidant defenses, healthy aging, beauty and overall well-being.

The company’s product portfolio has included Protandim, a line of supplements centered on the body’s antioxidant response, as well as LifeVantage skincare and wellness products. LifeVantage sells primarily through a direct-selling model that combines independent distributors, known as consultants, with digital and e-commerce channels.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets, including Canada, Japan, Australia, Mexico, Hong Kong and Taiwan. The company is led by President and Chief Executive Officer Steve Fife.

Key Stats

• Today's Range: $6.13 to $6.38
• 50-Day Range: $6.11 to $6.84
• 52-Week Range: $3.90 to $11.71
• Volume: 22,265 shs
• Average Volume: 50,746 shs
• Market Capitalization: $77.69 million
• P/E Ratio: 15.50
• Dividend Yield: 3.23%
• Price Target: $5.50
• Consensus Rating: Hold

Lifevantage Stock Analysis - MarketRank™

Lifevantage scored higher than 42% of companies evaluated by MarketBeat, and ranked 124th out of 174 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.4 / 5
• Analyst Rating: Hold

Consensus Rating

Lifevantage has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

Downside Risk

Lifevantage has a consensus price target of $5.50, representing about 11.3% downside from its current price of $6.20.

Amount of Analyst Coverage

Lifevantage has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 35.90%

Earnings Growth

Earnings for Lifevantage are expected to grow by 35.90% in the coming year, from $0.39 to $0.53 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Lifevantage is 15.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.96.

Price to Earnings Ratio vs. Sector

The P/E ratio of Lifevantage is 15.50, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 14.08.

Price to Book Value per Share Ratio

Lifevantage has a P/B Ratio of 2.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.49% of the float of Lifevantage has been sold short.

Short Interest Ratio / Days to Cover

Lifevantage has a short interest ratio ("days to cover") of 22.22, which indicates bearish sentiment.

Change versus previous month

Short interest in Lifevantage has recently increased by 1.12%, indicating that investor sentiment is decreasing.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Lifevantage pays a meaningful dividend of 3.24%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Lifevantage has only been increasing its dividend for 3 years.

Dividend Coverage

The dividend payout ratio of Lifevantage is 50.00%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Lifevantage will have a dividend payout ratio of 37.74% next year. This indicates that Lifevantage will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.51

News Sentiment

Lifevantage has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Lifevantage this week, compared to 2 articles on an average week.

MarketBeat Follows

1 people have added Lifevantage to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Lifevantage insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $55,649.00 in company stock.

Percentage Held by Insiders

21.95% of the stock of Lifevantage is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

35.32% of the stock of Lifevantage is held by institutions.

Company Calendar

• Last Earnings: 8/27/2026
• Record date for 9/15 Dividend: 9/01/2026
• Ex-Dividend for 9/15 Dividend: 9/01/2026
• Dividend Payable: 9/15/2026
• Today: 9/18/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NASDAQ:LFVN
• CIK: 849146
• Web: www.lifevantage.com
• Phone: (801) 432-9000
• Fax: 801-880-0699
• Employees: 223
• Year Founded: 1988

Price Target and Rating

• Average Price Target for Lifevantage: $5.50
• High Price Target: $6.00
• Low Price Target: $5.00
• Potential Upside/Downside: -11.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.40
• Trailing P/E Ratio: 15.50
• Forward P/E Ratio: 15.90
• P/E Growth: N/A
• Net Income: $5.07 million
• Net Margins: 2.78%
• Pretax Margin: 3.32%
• Return on Equity: 21.56%
• Return on Assets: 11.62%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.89
• Quick Ratio: 1.09

Sales & Book Value

• Annual Sales: $182.59 million
• Price / Sales: 0.43
• Cash Flow: $0.79 per share
• Price / Cash Flow: 7.81
• Book Value: $2.66 per share
• Price / Book: 2.33

Miscellaneous

• Outstanding Shares: 12,530,000
• Free Float: 9,777,000
• Market Cap: $77.69 million
• Optionable: Optionable
• Beta: 0.73